Apotex Antitrust Claims Tossed From Daiichi IP Spat
Apotex Corp. will not be able to pursue antitrust claims against Daiichi Sankyo Co. Ltd. in a lawsuit over the Canadian drugmaker's attempts to make a generic version of Daiichi Sankyo's...To view the full article, register now.
Already a subscriber? Click here to view full article